Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
T Kenakin - The FASEB journal, 2001 - Wiley Online Library
Concepts regarding the mechanisms by which drugs activate receptors to produce
physiological response have progressed beyond considering the re¬ ceptor as a simple on …
physiological response have progressed beyond considering the re¬ ceptor as a simple on …
Efficacy as a vector: the relative prevalence and paucity of inverse agonism
T Kenakin - Molecular pharmacology, 2004 - ASPET
This article describes the expected phenotypic behavior of all types of ligands in
constitutively active receptor systems and, in particular, the molecular mechanisms of …
constitutively active receptor systems and, in particular, the molecular mechanisms of …
Complete sequence of a novel protein containing a femtomolar‐activity‐dependent neuroprotective peptide
M Bassan, R Zamostiano, A Davidson… - Journal of …, 1999 - Wiley Online Library
The vulnerability of neurons and the irreversibility of loss make discoveries of
neuroprotective compounds fundamentally important. Here, the complete coding sequence …
neuroprotective compounds fundamentally important. Here, the complete coding sequence …
The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide
EM Lutz, WJ Sheward, KM West, JA Morrow… - FEBS …, 1993 - Wiley Online Library
We have cloned and sequenced a cDNA (RPR4) encoding a new member of the
secretin/calcitonin/parathyroid hormone (PTH) receptor family. RPR4 was identified by PCR …
secretin/calcitonin/parathyroid hormone (PTH) receptor family. RPR4 was identified by PCR …
Cloning and characterization of the human activity-dependent neuroprotective protein
R Zamostiano, A Pinhasov, E Gelber… - Journal of Biological …, 2001 - ASBMB
We have recently cloned the mouse activity-dependent neuroprotective protein (ADNP).
Here, we disclose the cloning of human ADNP (hADNP) from a fetal brain cDNA library …
Here, we disclose the cloning of human ADNP (hADNP) from a fetal brain cDNA library …
Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos
FACTORS controlling central nervous system (CNS) growth immediately after neurulation
are mostly unknown. Vasoactive intestinal peptide (VIP) receptors are widely distributed in …
are mostly unknown. Vasoactive intestinal peptide (VIP) receptors are widely distributed in …
A femtomolar-acting neuroprotective peptide.
DE Brenneman, I Gozes - The Journal of clinical …, 1996 - Am Soc Clin Investig
A novel 14-amino acid peptide, with stress-protein-like sequences, exhibiting
neuroprotection at unprecedented concentrations, is revealed. This peptide prevented …
neuroprotection at unprecedented concentrations, is revealed. This peptide prevented …
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.
Neurodegenerative diseases, in which neuronal cell disintegrate, bring about deteriorations
in cognitive functions as is evidenced in millions of Alzheimer patients. A major …
in cognitive functions as is evidenced in millions of Alzheimer patients. A major …
Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze
Activity-dependent neurotrophic factor (ADNF) is a glia-derived protein that is
neuroprotective at femtomolar concentrations. A nine-amino acid peptide derived from …
neuroprotective at femtomolar concentrations. A nine-amino acid peptide derived from …
In vitro properties of a high affinity selective antagonist of the VIP1 receptor
P Gourlet, P De Neef, J Cnudde, M Waelbroeck… - Peptides, 1997 - Elsevier
Gourlet, P., P. De Neef, J. Cnudde, M. Waelbroeck and P. Robberecht. In vitro properties of a
high affinity selective antagonist of the VIP1 receptor. Peptides 18 (10) 1555–1560, 1997 …
high affinity selective antagonist of the VIP1 receptor. Peptides 18 (10) 1555–1560, 1997 …